Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety

Biopharma

Roche’s Tecentriq shows promise in resectable NSCLC: key takeaways for the market Roche’s Tecentriq shows promise in resectable NSCLC: key takeaways for the market
Blog June 18, 2021
Roche’s Tecentriq shows promise in resectable NSCLC: key takeaways for the market
Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021 Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021
Blog June 16, 2021
Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021
Top 10 oncology breakthroughs shared at ASCO 2021 Top 10 oncology breakthroughs shared at ASCO 2021
Blog June 8, 2021
Top 10 oncology breakthroughs shared at ASCO 2021
Amazon and Walmart wade into U.S. telehealth and digital pharmacy Amazon and Walmart wade into U.S. telehealth and digital pharmacy
Blog May 31, 2021
Amazon and Walmart wade into U.S. telehealth and digital pharmacy
Pharma regulatory compliance Pharma regulatory compliance
Blog May 20, 2021
State review boards take on drug prices amid Congressional inaction
How to get drugs reimbursed in Singapore, ranking as the world’s most efficient healthcare system How to get drugs reimbursed in Singapore, ranking as the world’s most efficient healthcare system
Blog April 9, 2021
How to get drugs reimbursed in Singapore, ranking as the world’s most efficient healthcare system
Blog March 11, 2021
Immuno-oncology breakthroughs: from precision medicine to modulating the tumor microenvironment
DRG becomes Clarivate DRG becomes Clarivate
Blog March 1, 2021
DRG becomes Clarivate
Digital pharmacies posed for growth in a post-pandemic world Digital pharmacies posed for growth in a post-pandemic world
Blog February 26, 2021
Digital pharmacies posed for growth in a post-pandemic world
Medtech insights - Medtech portfolio strategy - ip litigation data Medtech insights - Medtech portfolio strategy - ip litigation data
Blog February 25, 2021
The unmet need for precision medicine in Lyme disease